Ed Dougherty

Ed advises medical device, diagnostics, and digital health companies, as well as those developing AI-enabled diagnostics and therapeutics to develop actionable strategies for US marketing clearance or approval, rapid adoption, and reimbursement.

For 30 years, Ed has worked directly with founders, company executives, board members, and investors to help them develop a strategic understanding of the many “healthcare markets” in the US and to prepare to take the concrete steps needed to enter these markets successfully. 

He advises companies in the US, UK, EU, the Nordics, Israel, and South Korea, and has authored articles about health economics and served as contributing editor to publications on global market access.